Measuring young adult appeal for menthol and non-menthol cigarettes: protocol of a clinical trial using both laboratory and intensive longitudinal methods (PRISM)

Amy M Cohn, Wallace Pickworth, Janet Audrain-McGovern, James Murphy, Andrea C Villanti, Donald Hedeker, Delaney Dunn, Riley Wyatt, Taylor Niznik, Whitney Cotten, Michael Smith, Sarah J Ehlke, Amy M Cohn, Wallace Pickworth, Janet Audrain-McGovern, James Murphy, Andrea C Villanti, Donald Hedeker, Delaney Dunn, Riley Wyatt, Taylor Niznik, Whitney Cotten, Michael Smith, Sarah J Ehlke

Abstract

Introduction: Although the Food and Drug Administration banned other characterising flavours in cigarettes, menthol cigarettes are still available to consumers. Young adult new smokers are initiating with menthol cigarettes, such that the prevalence of young adults menthol versus non-menthol smokers is increasing. Experimentation with menthol cigarettes is associated with progression to regular smoking and nicotine dependence. This ongoing clinical trial in young adult smokers measures appeal and the reinforcing value of smoking menthol versus non-menthol cigarettes and the impact of these variables on changes in smoking behaviour at a 6-month follow-up.

Methods and analysis: Reinforcement for menthol smoking is assessed in the laboratory using a validated behavioural economic choice task, and appeal is measured in the natural environment using ecological momentary assessment (EMA). Analyses will examine differences between menthol and non-menthol cigarette smoking on measures of subjective response in the laboratory and via EMA, and how subjective response mediates the association between menthol preference at baseline and smoking outcomes at follow-up.

Ethics and dissemination: This protocol was approved by the University of Oklahoma Health Sciences Center Institutional Review Board (#10581). The findings will isolate the unique effects of menthol in smoking and will help inform regulatory decisions about the abuse liability of menthol cigarettes. Findings will be disseminated through peer-reviewed journal articles and presentations at national and international conferences.

Trial registration number: NCT03953508.

Keywords: epidemiology; public health; statistics & research methods; substance misuse.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Nonnemaker J, Hersey J, Homsi G, et al. . Initiation with menthol cigarettes and youth smoking uptake. Addiction 2013;108:171–8. 10.1111/j.1360-0443.2012.04045.x
    1. Hersey JC, Ng SW, Nonnemaker JM, et al. . Are menthol cigarettes a starter product for youth? Nicotine Tob Res 2006;8:403–13. 10.1080/14622200600670389
    1. Wackowski O, Delnevo CD. Menthol cigarettes and indicators of tobacco dependence among adolescents. Addict Behav 2007;32:1964–9. 10.1016/j.addbeh.2006.12.023
    1. Carpenter CL, Jarvik ME, Morgenstern H, et al. . Mentholated cigarette smoking and lung-cancer risk. Ann Epidemiol 1999;9:114–20. 10.1016/S1047-2797(98)00042-8
    1. Kreslake JM, Wayne GF, Alpert HR, et al. . Tobacco industry control of menthol in cigarettes and targeting of adolescents and young adults. Am J Public Health 2008;98:1685–92. 10.2105/AJPH.2007.125542
    1. Kreslake JM, Wayne GF, Connolly GN. The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res 2008;10:705–15. 10.1080/14622200801979134
    1. Lee YO, Glantz SA. Menthol: putting the pieces together. Tob Control 2011;20 Suppl 2:ii1–7. 10.1136/tc.2011.043604
    1. Ferris Wayne G, Connolly GN, Wayne GF, Application CGN. Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents. Nicotine Tob Res 2004;6 Suppl 1:43–54. 10.1080/14622203310001649513
    1. Carpenter CM, Wayne GF, Connolly GN. The role of sensory perception in the development and targeting of tobacco products. Addiction 2007;102:136–47. 10.1111/j.1360-0443.2006.01649.x
    1. US Food Drug Administration . Tobacco products scientific Advisory Committee (TPSAC). menthol cigarettes and public health: review of the scientific evidence and recommendations. Rockville, MD: US food and drug administration. center for tobacco products, 2011.
    1. US Food Drug Administration . Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes, 2013.
    1. Hymowitz N, Mouton C, Edkholdt H. Menthol cigarette smoking in African Americans and whites. Tob Control 1995;4:194–5. 10.1136/tc.4.2.194b
    1. Finkenauer R. Emotion, motivation, and executive functioning as predictors of smoking status. Wayne State University, 2009.
    1. Audrain-McGovern J, Strasser AA, Wileyto EP. The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alcohol Depend 2016;166:263–7. 10.1016/j.drugalcdep.2016.06.030
    1. Strasser AA, Ashare RL, Kaufman M, et al. . The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer Epidemiol Biomarkers Prev 2013;22:382–9. 10.1158/1055-9965.EPI-12-1097
    1. Gordon SM, Brinkman MC, Meng RQ, et al. . Effect of cigarette menthol content on mainstream smoke emissions. Chem Res Toxicol 2011;24:1744–53. 10.1021/tx200285s
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Lawrence Erlbaum, 1988.
    1. Pickworth WB, Moolchan ET, Berlin I, et al. . Sensory and physiologic effects of menthol and non-menthol cigarettes with differing nicotine delivery. Pharmacol Biochem Behav 2002;71:55–61. 10.1016/S0091-3057(01)00623-2
    1. Pickworth W, Canlas L, Rosenberry Z, et al. . Make your own cigarette smoking: toxicant exposure and behavioral changes. Drug Alcohol Depend 2014;140:e177. 10.1016/j.drugalcdep.2014.02.496
    1. Rosenberry ZR, Pickworth WB, Koszowski B. Large Cigars: smoking topography and toxicant exposure. NICTOB 2016;63(30:ntw289. 10.1093/ntr/ntw289
    1. Pickworth WB, Rosenberry ZR, O'Grady KE, et al. . Dual use of cigarettes, little Cigars, Cigarillos, and large Cigars: smoking topography and toxicant exposure. Tob Regul Sci 2017;3:72–83. 10.18001/TRS.3.2(Suppl1).8
    1. Audrain-McGovern J, Strasser AA, Ashare R, et al. . Reinforcing value of smoking relative to physical activity and the effects of physical activity on smoking abstinence symptoms among young adults. Exp Clin Psychopharmacol 2015;23:477–85. 10.1037/pha0000051
    1. Audrain-McGovern J, Wileyto EP, Ashare R, et al. . Reward and affective regulation in depression-prone smokers. Biol Psychiatry 2014;76:689–97. 10.1016/j.biopsych.2014.04.018
    1. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1990;69:763–5.
    1. Heatherton TF, Kozlowski LT, Frecker RC, et al. . The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991;86:1119–27. 10.1111/j.1360-0443.1991.tb01879.x
    1. Allen B, Cruz TB, Leonard E, et al. . Development and validation of a scale to assess attitudes and beliefs about menthol cigarettes among African American smokers. Eval Health Prof 2010;33:414–36. 10.1177/0163278710383276
    1. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289. 10.1001/archpsyc.1986.01800030107013
    1. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 2001;3:7–16. 10.1080/14622200020032051
    1. Westman E, Levin E, Rose J. Smoking while wearing the nicotine patch. is smoking satisfying or harmful. Slack Inc 6900 grove RD, THOROFARE, NJ 08086, 1992: A871.
    1. Behm FM, Rose JE. Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low TAR cigarettes. Exp Clin Psychopharmacol 1994;2:143–53. 10.1037/1064-1297.2.2.143
    1. Morean ME, de Wit H, King AC, et al. . The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology 2013;227:177–92. 10.1007/s00213-012-2954-z
    1. Cappelleri JC, Bushmakin AG, Baker CL, et al. . Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 2007;32:912–23. 10.1016/j.addbeh.2006.06.028

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する